
Vaccinex Inc
NASDAQ:VCNX

Intrinsic Value
The intrinsic value of one
VCNX
stock under the Base Case scenario is
3.19
USD.
Compared to the current market price of 0.71 USD,
Vaccinex Inc
is
Undervalued by 78%.
The Intrinsic Value is calculated as the average of DCF and Relative values:

Valuation History
Vaccinex Inc
Loading...
Fundamental Analysis


Revenue & Expenses Breakdown
Vaccinex Inc
Balance Sheet Decomposition
Vaccinex Inc
Current Assets | 2.5m |
Cash & Short-Term Investments | 1.1m |
Receivables | 838k |
Other Current Assets | 586k |
Non-Current Assets | 65k |
PP&E | 65k |
Free Cash Flow Analysis
Vaccinex Inc
USD | |
Free Cash Flow | USD |
Earnings Waterfall
Vaccinex Inc
Revenue
|
601k
USD
|
Operating Expenses
|
-19.3m
USD
|
Operating Income
|
-18.7m
USD
|
Other Expenses
|
101k
USD
|
Net Income
|
-18.6m
USD
|
VCNX Profitability Score
Profitability Due Diligence
Vaccinex Inc's profitability score is 43/100. The higher the profitability score, the more profitable the company is.

Score
Vaccinex Inc's profitability score is 43/100. The higher the profitability score, the more profitable the company is.
VCNX Solvency Score
Solvency Due Diligence
Vaccinex Inc's solvency score is 40/100. The higher the solvency score, the more solvent the company is.

Score
Vaccinex Inc's solvency score is 40/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
VCNX Price Targets Summary
Vaccinex Inc
Dividends
Current shareholder yield for VCNX is
.
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
The intrinsic value of one
VCNX
stock under the Base Case scenario is
3.19
USD.
Compared to the current market price of 0.71 USD,
Vaccinex Inc
is
Undervalued by 78%.